Bienville Health Science Partners, LP — Form D
Bienville Health Science Partners, LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2014-02-21. $16.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2014-02-21
- Form: D
- Accession: 0001600546-14-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b
- Amount sold: $16.1M
- Minimum investment: $1.0M
- Investors: 29
- Date of first sale: 2014-01-27
- Security types: fund interests
- SEC file number: 021-212335
Issuer
- Name: Bienville Health Science Partners, LP
- CIK: 0001600546
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 405 LEXINGTON AVENUE, NEW YORK, NY, 10174
- Phone: 212-226-7348
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Ralph Reynolds | Executive Officer | New York, NY |
| William Stimpson II | Executive Officer | New York, NY |
| Cullen Thompson | Executive Officer | New York, NY |
More